105 related articles for article (PubMed ID: 30147445)
1. The Associations between Toll-Like Receptor 9 Gene Polymorphisms and Cervical Cancer Susceptibility.
Tian S; Zhang L; Yang T; Wei X; Zhang L; Yu Y; Li Y; Cao D; Yang X
Mediators Inflamm; 2018; 2018():9127146. PubMed ID: 30147445
[TBL] [Abstract][Full Text] [Related]
2. Gene Polymorphisms of Toll-Like Receptor 9 -1486T/C and 2848G/A in Cervical Cancer Risk.
Mu X; Zhao J; Yuan X; Zhao X; Yao K; Liu Y; Zhao X
Int J Gynecol Cancer; 2015 Sep; 25(7):1173-8. PubMed ID: 26270118
[TBL] [Abstract][Full Text] [Related]
3. A Meta-Analysis for Association of XRCC3 rs861539, MTHFR rs1801133, IL-6 rs1800795, IL-12B rs3212227, TNF-α rs1800629, and TLR9 rs352140 Polymorphisms with Susceptibility to Cervical Carcinoma.
Parsaeian SF; Asadian F; Karimi-Zarchi M; Setayesh S; Javaheri A; Tabatabaie RS; Dastgheib SA; Golestanpour H; Neamatzadeh H
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3419-3431. PubMed ID: 34837895
[TBL] [Abstract][Full Text] [Related]
4. TLR9 gene polymorphism (rs187084, rs352140): association with acute rejection and estimated glomerular filtration rate in renal transplant recipients.
Kim TH; Jeong KH; Kim SK; Lee SH; Ihm CG; Lee TW; Moon JY; Yoon YC; Chung JH; Park SJ; Kang SW; Kim YH
Int J Immunogenet; 2013 Dec; 40(6):502-8. PubMed ID: 23758740
[TBL] [Abstract][Full Text] [Related]
5. The Relationship of the TLR9 and TLR2 Genetic Polymorphisms with Cervical Cancer Risk: a Meta-Analysis of Case-Control Studies.
Yang S; Liu L; Xu D; Li X
Pathol Oncol Res; 2020 Jan; 26(1):307-315. PubMed ID: 30215163
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility.
Pandey S; Mittal B; Srivastava M; Singh S; Srivastava K; Lal P; Mittal RD
Mol Biol Rep; 2011 Oct; 38(7):4715-21. PubMed ID: 21132533
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in Toll-like receptors genes changes the host's immune response and is associated with cervical cancer.
Moura EL; Santos IFD; Freitas PP; Silva DMD; Santos ACMD; Lira Neto AB; Silva ACPE; Barbosa NR; Nascimento CA; Balliano TL; Fraga CAC; Farias KF; Figueiredo EVMS
Immunobiology; 2022 Mar; 227(2):152187. PubMed ID: 35158151
[TBL] [Abstract][Full Text] [Related]
8. TLR9 gene polymorphism -1486T/C (rs187084) is associated with uterine cervical neoplasm in Mexican female population.
Martínez-Campos C; Bahena-Román M; Torres-Poveda K; Burguete-García AI; Madrid-Marina V
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2437-2445. PubMed ID: 28819773
[TBL] [Abstract][Full Text] [Related]
9. Associations of toll-like receptor 4 and 2 gene polymorphisms with susceptibility to ankylosing spondylitis: A meta-analysis.
Gao S; Zhang J; Xu T; Xun C; Cao R; Guo H; Liang W; Sheng W
Int J Immunogenet; 2021 Apr; 48(2):219-228. PubMed ID: 33369094
[TBL] [Abstract][Full Text] [Related]
10. Associations between TLR9 polymorphisms and cancer risk: evidence from an updated meta-analysis of 25,685 subjects.
Wan GX; Cao YW; Li WQ; Li YC; Zhang WJ; Li F
Asian Pac J Cancer Prev; 2014; 15(19):8279-85. PubMed ID: 25339018
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution.
Zidi S; Sghaier I; Gazouani E; Mezlini A; Yacoubi-Loueslati B
Pathol Oncol Res; 2016 Apr; 22(2):323-30. PubMed ID: 26548749
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.
Zidi S; Verdi H; Yilmaz-Yalcin Y; Yazici AC; Gazouani E; Mezlini A; Atac FB; Yacoubi-Loueslati B
Bull Cancer; 2014 Oct; 101(10):E31-5. PubMed ID: 25373689
[TBL] [Abstract][Full Text] [Related]
13. Association of polymorphisms in Toll-like receptors 4 and 9 with risk of pulmonary tuberculosis: a meta-analysis.
Zhao L; Liu K; Kong X; Tao Z; Wang Y; Liu Y
Med Sci Monit; 2015 Apr; 21():1097-106. PubMed ID: 25889916
[TBL] [Abstract][Full Text] [Related]
14. A genetic variant in the promoter region of Toll-like receptor 9 and cervical cancer susceptibility.
Chen X; Wang S; Liu L; Chen Z; Qiang F; Kan Y; Shen Y; Wu J; Shen H; Hu Z
DNA Cell Biol; 2012 May; 31(5):766-71. PubMed ID: 22059466
[TBL] [Abstract][Full Text] [Related]
15. The TLR9 gene polymorphisms and the risk of cancer: evidence from a meta-analysis.
Zhang L; Qin H; Guan X; Zhang K; Liu Z
PLoS One; 2013; 8(8):e71785. PubMed ID: 23990988
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Toll-like Receptor 9 polymorphism in cervical cancer development.
Roszak A; Lianeri M; Sowińska A; Jagodziński PP
Mol Biol Rep; 2012 Aug; 39(8):8425-30. PubMed ID: 22714906
[TBL] [Abstract][Full Text] [Related]
17. The possible association between the presence of an MPO -463 G > A (rs2333227) polymorphism and cervical cancer risk.
Shi X; Li B; Yuan Y; Chen L; Zhang Y; Yang M; Wang J; Qin D
Pathol Res Pract; 2018 Aug; 214(8):1142-1148. PubMed ID: 29937309
[TBL] [Abstract][Full Text] [Related]
18. Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects.
Zeng X; Zhang Y; Yue T; Zhang T; Wang J; Xue Y; An R
Oncotarget; 2017 Jan; 8(2):2249-2260. PubMed ID: 27903984
[TBL] [Abstract][Full Text] [Related]
19. Association between HLA-DP Gene Polymorphisms and Cervical Cancer Risk: A Meta-Analysis.
Cheng L; Guo Y; Zhan S; Xia P
Biomed Res Int; 2018; 2018():7301595. PubMed ID: 30009173
[No Abstract] [Full Text] [Related]
20. TLR9 -1486T/C and 2848C/T SNPs Are Associated with Human Cytomegalovirus Infection in Infants.
Paradowska E; Jabłońska A; Studzińska M; Skowrońska K; Suski P; Wiśniewska-Ligier M; Woźniakowska-Gęsicka T; Nowakowska D; Gaj Z; Wilczyński J; Leśnikowski ZJ
PLoS One; 2016; 11(4):e0154100. PubMed ID: 27105145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
